• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate (CAS No. 53101-04-5): A Comprehensive Overview

Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate, a compound with the chemical formula C₁₂H₉NO₆S, is a derivative of thiazole that has garnered significant attention in the field of pharmaceutical research due to its unique structural and pharmacological properties. This compound is characterized by the presence of a nitro group on the phenyl ring and an ester functional group on the thiazole core, which contribute to its versatile reactivity and potential biological activity. The CAS number 53101-04-5 uniquely identifies this molecule and distinguishes it from other isomers or analogs.

The thiazole scaffold is a prominent heterocyclic system in medicinal chemistry, known for its broad spectrum of biological activities. Thiazole derivatives have been extensively studied for their antimicrobial, antifungal, anti-inflammatory, and anticancer properties. Among these derivatives, Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate stands out due to its ability to modulate various biological pathways. The nitro group in the phenyl ring enhances electrophilicity, making the compound a valuable intermediate in synthetic chemistry and a potential prodrug candidate.

In recent years, there has been growing interest in developing novel thiazole-based compounds that exhibit enhanced efficacy and reduced toxicity compared to existing drugs. Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate has been investigated for its potential role in inhibiting key enzymes involved in cancer progression. Studies have shown that this compound can interact with target proteins such as kinases and transcription factors, thereby disrupting signaling pathways that promote cell proliferation and survival. These findings make it a promising candidate for further development into an anticancer therapeutic agent.

The ester functional group in Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate also contributes to its pharmacological profile. Ester derivatives are known to exhibit improved bioavailability and solubility, which can enhance drug delivery and absorption. This property makes the compound particularly interesting for oral administration, where rapid absorption into the bloodstream is crucial for achieving therapeutic effects. Additionally, the ester group can be further modified through hydrolysis or enzymatic degradation, offering flexibility in drug design and development.

Recent advancements in computational chemistry have enabled researchers to predict the binding affinity and interaction modes of Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate with biological targets. Molecular docking studies have revealed that this compound can bind tightly to specific pockets on target proteins, leading to potent inhibition of their activity. These computational predictions have been validated through experimental studies, confirming the compound's potential as a lead molecule for drug discovery.

The synthesis of Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The process typically begins with the condensation of 4-nitrobenzaldehyde with thiosemicarbazide under acidic conditions to form the corresponding thiazole derivative. Subsequent esterification with ethanoic anhydride yields the final product. The synthesis route has been optimized to minimize side reactions and maximize efficiency, making it suitable for large-scale production.

In conclusion, Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate (CAS No. 53101-04-5) is a structurally unique compound with significant potential in pharmaceutical applications. Its ability to modulate key biological pathways makes it a valuable tool for drug discovery and development. Further research is warranted to explore its full therapeutic potential and optimize its pharmacokinetic properties for clinical use.

• 1141669-77-3(4-(2-Nitrophenyl)thiazole-2-carboxylic acid)
• 185245-05-0(4-(3-Nitrophenyl)thiazole-2-carboxylic acid)
• 31877-30-2(Ethyl 4-phenylthiazole-2-carboxylate)
• 172848-60-1(Ethyl 4-(2-Nitrophenyl)Thiazole-2-Carboxylate)
• 4415-05-8(4-(4-Nitrophenyl)thiazole-2-carboxylic acid)
• 885279-68-5(Methyl 4-(3-nitrophenyl)thiazole-2-carboxylate)
• 885279-72-1(4-(3-Amino-phenyl)-thiazole-2-carboxylic acid methyl ester)
• 53101-01-2(Ethyl 4-(4-Methylphenyl)-2-thiazole Carboxylate)
• 53101-05-6(Ethyl 4-(3-nitrophenyl)thiazole-2-carboxylate)
• 491577-82-3(Ethyl 4-(4-aminophenyl)thiazole-2-carboxylate)